Bolivia, Plurinational State of vs Republic of Moldova: Access to anti-retroviral drugs, female
Bolivia, Plurinational State of
62.0%
in 2024
Republic of Moldova
62.0%
in 2024
Bolivia, Plurinational State of rank
99th
Republic of Moldova rank
99th
Access to anti-retroviral drugs, female over time
- Bolivia, Plurinational State of
- Republic of Moldova
How they compare
Bolivia, Plurinational State of currently reports 62.0% against 62.0% in Republic of Moldova, a difference of 0.0%.
The two have swapped places 10 times across 25 shared years of data; in 2000 it was Republic of Moldova ahead.
Bolivia, Plurinational State of ranks 99th and Republic of Moldova ranks 99th of 141 countries.
Bolivia, Plurinational State of has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Bolivia, Plurinational State of | Republic of Moldova | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 2.1% | 1.4% | 0.7% | Bolivia, Plurinational State of |
| 2010s | 29.4% | 27.8% | 1.6% | Bolivia, Plurinational State of |
| 2020s | 57.6% | 56.4% | 1.2% | Bolivia, Plurinational State of |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Bolivia, Plurinational State of or Republic of Moldova?
- Bolivia, Plurinational State of, at 62.0% against 62.0% in Republic of Moldova as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Bolivia, Plurinational State of and Republic of Moldova?
- 0.0%, with Bolivia, Plurinational State of ahead.
- How many years of comparable data are there for Bolivia, Plurinational State of and Republic of Moldova?
- 25 years are reported by both, from 2000 to 2024.
- How do Bolivia, Plurinational State of and Republic of Moldova rank globally for access to anti-retroviral drugs, female?
- Bolivia, Plurinational State of ranks 99th and Republic of Moldova ranks 99th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.